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Abstract Muscle health is a critical component in the
struggle against physical frailty and the efforts to
maintain metabolic health until the limit of chronolog-
ical age. Consensus opinion is to evaluatemuscle health
in terms of muscle mass, strength and functional
capability. There has been considerable variability in
the components of muscle health which have been
investigated in addition to variability in the tools of
assessment and protocol for measurement. This is in
stark contrast to the validated measurement of bone
health across the adult life span. The purpose of this
review was to identify indices of muscle mass, strength
and functional capability most responsive to change
with ageing andwhere possible to provide an estimate of
the rate of change. We suggest lean tissue mass (LTM)
or skeletal muscle (SM) is best evaluated from the thigh
region due to its greater responsiveness to ageing
compared to the whole body. The anterior compartment
of the thigh region undergoes a preferential age-related
decline in SM and force generating capacity. Therefore,
we suggest that knee extensor torque is measured to
represent the force generating capacity of the thigh and
subsequently, to express muscle quality (strength per
unit tissue). Finally, we suggest measures of functional
capability which allow participants perform to a greater
maximum are most appropriate to track age-related
difference in functional capacity across the adult
lifespan. This is due to their ability encompass a broad
spectrum of abilities. This review suggests indices of
muscular health for which reference ranges can be
generated across the lifespan.
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Background
Life expectancy in Europe is set to increase by 8.5 and
6.9 years for men (84.5 years) and women
(89.0 years) respectively by the year 2060. However,
up until 2009, ‘healthy’ life expectancy in Europe
lagged two decades behind chronological age (Rechel
et al. 2013). Old age at best leads to compromised
physical prowess (Drey et al. 2016) and at worst can
lead to a crippling loss of independence (Wang et al.
2013), often accompanied by metabolic disease
(Leenders et al. 2011). Muscle health is therefore a
critical component in the struggle against physical
frailty and the efforts to maintain metabolic health
until the limit of chronological age. Sarcopenia comes
from the Greek words ‘Sarx’ meaning flesh and
‘penia’ meaning loss and has been used to describe the
age related decline in muscle mass (Rosenberg 1989).
Many authors since (Morley et al. 2001; Cruz-Jentoft
et al. 2010), have used sarcopenia as an all-encom-
passing term, to describe the accompanying loss of
strength and functional capability with age.
Originally, the decline in muscular strength was
thought to be caused by a loss of muscle mass
(Frontera et al. 1991). In an approach similar to the
measurement of bone health, researchers focused on
developing diagnostic criteria for muscle health based
on classifying individuals as having high or low
indices of muscle mass relative to a healthy young
adult norm (Gallagher et al. 1997; Baumgartner et al.
1998; Janssen et al. 2000). There is now a growing
body of evidence spanning over 3 decades (Larsson
et al. 1979; Clarkson et al. 1981), that suggests muscle
mass and strength are not as closely linked as
previously assumed (Clark and Manini 2008; Manini
and Clark 2012). Prior to a change in absolute mass or
cross-sectional area (CSA), muscle undergoes a series
of physiological changes with ageing that are implicit
in a decrease in strength. There is a reduction in the
number of motor units and a resultant increase in the
size of motor units because of the compensatory
collateral sprouting by surviving neurons (Vander-
voort 2002; Piasecki et al.2016a, b). Furthermore,
maximal motor unit firing rates are reported to be
35–40% lower than young adults (Kamen et al. 1995)
and exhibit greater variability in motor unit discharge
(Christou 2011). Subsequently, at the tissue level the
excitation–contraction coupling processes are thought
to be impaired due to impairments in calcium release
from the sarcoplasmic reticulum. These changes are
compounded by an increase in inter and intramuscular
adipocyte content (Delmonico et al. 2009) that is
thought to directly impair cross-bridge kinetics
(D’Antona et al. 2003). As a result of the increase in
fat infiltration and connective tissue, the net contrac-
tile mass is less. In fact, non-contractile mass can
account for 15% of total muscle CSA, an estimate that
is 2.5 fold greater than in young controls (Taaffe et al.
2009).
Consequently, there is a growing interest in the
measurement of age-related change in muscle perfor-
mance rather than size alone. As a result, the
consensus in Europe (Cruz-Jentoft et al. 2010) and
America (Fielding et al. 2011) among expert working
groups is that muscle health should be assessed in
terms of muscle mass, muscle strength and functional
capability. Low relative skeletal muscle (SM) mass
has been shown to be associated with functional
impairment (Janssen et al. 2002) measured by the short
physical performance battery (SPPB) (Guralnik et al.
1994). Increasing knee extensor torque has been
associated with improved walking speed and the
ability to rise from a chair (Ostchega et al. 2004; Hairi
et al. 2010). Knee extensor speed of contraction has
been found to be predictive of gait speed in mobility
limited older adults (Sayers et al. 2005). Despite
established relationships between muscle mass,
strength and functional capability in mobility limited
older adults, comparatively little is known about the
time course and transition to functional impairment in
healthy older ([50 y) adults (Murphy et al. 2014).
Furthermore, there has been considerable variability in
the components of muscle mass, strength and func-
tional capability which have been investigated in
addition to variability in the tools of assessment and
protocol for measurement. This is in stark contrast to
the validated measurement of bone health across the
adult life span (Kanis et al. 1994). The focus of this
review is not to discuss the mechanistic causes of
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functional impairment but to identify indices of
muscle mass, strength and functional capability most
responsive to change with ageing and where possible
to provide an estimate of the rate of change.
Age-related change in muscle or lean tissue mass
Currently, imaging methods including magnetic res-
onance imaging (MRI) and computed tomography
(CT) represent the accepted criterion method for
quantifying whole body and regional skeletal muscle
(SM). This is due to their ability to distinguish
between fat, skeletal muscle and other non-muscle
fat-free components such as connective tissue (Wang
et al. 1996; Mitsiopoulos et al. 1998; Levine et al.
2000). Dual energy x-ray absorptiometry (DXA),
more commonly used in the assessment of bone health
has been found to be a reliable cost effective method of
quantifying whole body and regional non-osseous lean
tissue mass (LTM) with a low radiation dose (Wang
et al. 1996; Levine et al. 2000). Despite a strong
correlation between CT and DXA in the estimation of
SM (r = 0.88, P\ 0.001), reporting the age-related
decline in SM using DXA requires caution as it has
been shown to overestimate whole body and regional
SM. This methodological issue may mask age or
therapeutic related changes in SM (Delmonico et al.
2008; Nilwik et al. 2013; Maden-Wilkinson et al.
2013).
Numerous studies have attempted to quantify the
rate of decline in SM as though it is a uniform process
which begins at the completion of growth (Gallagher
et al. 1997; Silva et al. 2010). The suggestion that
LTM begins to decline in the third decade stems from
studies evaluating the decline in skeletal mass relative
to bodymass which produces an inflated decline due to
an increase in fat mass (Janssen et al. 2002). Janssen
et al. (2000) suggest age is not associated with
appendicular SM, as measured by MRI, until
after *45 y. Furthermore, changes in whole body
LTM as measured by DXA or hydro-densitometry,
albeit less sensitive measures of SM, are subtle enough
not to be detected until after 60 y in either cross-
sectional (Kyle et al. 2001) or longitudinal (Hughes
et al. 2002) analysis. Estimating the age-related
decline in SM across the adult lifespan is difficult
due to incomplete data sets across age ranges which
have led to researchers using equations to predict
declines (Gallagher et al. 1997; Baumgartner et al.
1998). This has been compounded by existing litera-
ture containing multiple ethnic groups. There is
considerable variability in the age-related decline in
SM amongst Hispanics, African-American, Cau-
casian, and Asians. The rate of change in SM in these
ethnic groups differs between men and women
(Baumgartner et al. 1998; Janssen et al. 2002; Silva
et al. 2010). Therefore, it is recommended age-related
change in SM is reported according to gender and
ethnicity.
A 1–2% decline in SM after age *50 y is often
quoted in review papers on the topic of sarcopenia
(Thomas 2007; Rolland et al. 2008). In the section
below, we intend to demonstrate from the available
data that the estimate at the whole body is actually far
more conservative. Furthermore, we suggest the rate
of decline in SM for middle-aged (40–70 y) and older
([70 y) adults are not uniform nor are the rates of
decline at the whole body, appendicular or limb
specific regions of the body.
Frontera et al. (1991) reported stature (ht2) cor-
rected fat free mass (FFM; hydrostatic weighing) in
older (45–78 y) adults to decline at a rate of 3.4 and
3.1% per decade men and women respectively from a
cross sectional analysis. The per decade decline from
peak levels of SM is greater in men (4.2%) and women
(3.8%) when estimated using MRI (Janssen et al.
2000); perhaps due to the methodological differences
discussed above. These cross-sectional analysis which
suggest a rate of decline between 3.1 and 4.2% per
decade are in agreement with consensus among recent
reviewers (Narici and Maffulli 2010; Mitchell et al.
2012) who report that healthy adult LTM decli-
nes *20–28% between the 2nd and 8th decades of
life (3.3–4.6% per decade). Mitchell et al. (2012)
reviewed studies using indirect (total body potassium,
24 h urinary creatinine excretion) and direct methods
(MRI, CT, DXA) of assessing lean body mass between
the years of 1972 and 2011. The median decline per
decade was 4.7 and 3.7% in men and women
respectively. This decline becomes identifiable
at *45 y (Janssen et al. 2000) but is not statistically
different from a young adult until *50 y (Janssen
et al. 2000; Kyle et al. 2001; Hughes et al. 2002).
Considering the evidence above, a 0.3–0.5% per
annum decline in SM may be considered a more
realistic estimate of the change in SM as a result of
normal ageing than the 1–2% widely reported.
Biogerontology
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Site-specific changes in muscle or lean tissue mass
Appendicular SM is the main proponent of func-
tional capability. More specifically, the lower limbs
possess the major muscles involved in locomotion
such as walking, rising from a chair and stair
climbing. Therefore, it has been postulated that
appendicular or limb specific SM changes may be of
more functional significance. Lynch et al. (1999), as
part of the Baltimore Longitudinal Study of Aging
(BLSA), reported women to have a greater rate of
decline in leg LTM (DXA) than men between the
4th and 7th decade (4.9 vs. 2.6% per decade). These
findings were extended by Janssen et al. (2000) who
reported women to have a greater rate of SM (MRI)
decline in the lower extremities in comparison to
men (5.7 vs. 3.5%). More recently, although not
statistically significant, we reported mean age-related
difference in LTM (DXA) between the 6th and 7th
decade of life to be greater at the upper leg
compared to the whole body (5.3 vs. 1.8%) in
healthy women (Francis et al. 2016b). Furthermore,
our research group reported upper leg LTM but not
whole body LTM to increase following 12 weeks of
progressive resistance training (Francis et al. 2016a).
The results of these studies, in women at least,
suggest lower limb LTM is a more sensitive index of
age-related change in SM between the 4th and 7th
decade.
Perhaps the most robust analysis to date of age-
related change in muscle mass, strength and quality
was reported by the Healthy Aging and Body
Composition (HABC) study (Newman et al. 2003;
Goodpaster et al. 2006; Delmonico et al. 2009) when
describing adults in the 8th decade of life
(n = 3075). The HABC study measures lower limb
muscle or lean tissue mass via CT (thigh muscle
area) and DXA (total leg LTM); lower limb strength
via isokinetic knee extensor torque and muscle
quality by expressing strength per thigh muscle area
(N m/cm2) or total leg lean tissue (N m/kg). For the
purpose of this review we discuss the rate (per
decade) of decline in muscle health in cross-sectional
and longitudinal analysis from the HABC study. In
the case of longitudinal analysis, to provide the rate
(per decade) of decline it is necessary to pool all
ethnic male and all ethnic female data and divide the
percentage changes by the number of years (3 or
5 years) participants were followed.
Newman et al. (2003) reported leg LTM to decline
at a rate of 9–10% per decade during a cross-sectional
analysis of the 8th decade; almost double the rate
described in earlier decades. Three and 5 year follow
up studies of older adults, *72 years of age at
baseline, revealed a 9.8–11.7% per decade decline in
lower limb thigh muscle or lean tissue in men and a
6.4–9.0% decline in women (Goodpaster et al. 2006;
Delmonico et al. 2009). The results of the HABC study
indicate a greater rate of decline in lower limb SM or
LTM in those[70 y and unlike existing data prior to
70 y, men consistently lose more LTM in comparison
to women.
Within the lower limb, the anterior compartment
(knee extensors) of the thigh accounts for a greater
proportion of SM than the posterior compartment
(knee flexors). Frontera et al. (2008) reported total
thigh muscle area to decline 0.5% per annum during a
9 year follow up of adults (n = 12) in the 8th decade
of life. The decline was largely dominated by the
anterior compartment relative to the posterior com-
partment (5.7 vs. 3.2%). Further support for the
preferential decline in SM of the anterior compartment
has been provided with more recent evidence. Ogawa
et al. (2012) reported age to be inversely associated
with quadriceps femoris but not hamstring thickness
(Ultrasound; US) in women and Maden-Wilkinson
et al. (2013) reported quadriceps and hamstring SM to
be 30% and 18% lower in older (*72 y, n = 53)
adults compared to their younger (*22 y, n = 38)
counterparts. We suggest that lower limb LTM as
measured by DXA or quadriceps femoris SM as
measured by MRI, CT or US are the most responsive
indices of SM to ageing and given their association
with functional capability are worthy of being used to
generate reference ranges.
Age-related change in muscle strength
Isokinetic dynamometry is the most common method
of assessing voluntary strength in the appendicular
regions (Arnold et al. 1993; Li et al. 1996; Lund et al.
2005; Maffiuletti et al. 2007). Strength in the arms and
legs reach peak values between 25 and 35 y (As-
mussen and Heebollnielsen 1962), plateau or decline
slightly in those[40 y (Lindle et al. 1997; Metter
et al. 1997), show definite declines in those[50 y
(Lynch et al. 1999) and more rapid declines in
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those[65 y (Newman et al. 2003). Cross sectional
and longitudinal observations of age-related change in
strength vary between 8 and 15% per decade (Hurley
1995; Metter et al. 1999) in those up to *70 y. It is
generally accepted that the age-related decline in
strength is greater in longitudinal compared to cross
sectional observations (Clement 1974; Metter et al.
1997; Hughes et al. 2001; Goodpaster et al. 2006).
Men lose strength almost evenly between the upper
and lower extremities and at a greater rate than
women. However, women have a greater rate of
decline in the lower extremities relative to their upper
extremities (Lynch et al. 1999; Hughes et al. 2001).
Upper leg (knee extensor and flexors combined)
torque determined in cross-sectional and longitudinal
studies declines at a rate of 8–14% per decade from
peak levels up until age 70 y (Frontera et al. 1991;
Lynch et al. 1999; Francis et al. 2016b). These
estimates of age-related difference in maximal
strength are consistent despite differences in sample
size, protocol for isokinetic assessment andmethod for
reporting the decline (mean difference vs. regression).
Consistent with the preferential atrophy of SM in the
anterior compartment, the knee extensors account for
the majority of torque decline (Frontera et al. 2008;
Francis et al. 2016b). For adults in the 8th decade of
life the cross-sectional differences in knee extensor
torque increase to 19–22% per decade and up
to *27–38% during longitudinal analysis (Newman
et al. 2003; Goodpaster et al. 2006; Delmonico et al.
2009). The age-related change in knee extensor
strength observed in the HABC study is 2–5 times
greater than the SM loss in the thigh region.
Age-related change in muscle quality
Declines in grip and knee extensor strength have
been shown to occur independent of changes in limb
circumference, anthropometrically determined lean
body mass and thigh CSA, determined by CT
(Larsson et al. 1979; MacLennan et al. 1980;
Kallman et al. 1990; Overend et al. 1992). Recent
evidence, discussed above, has had the benefit of
modern imaging techniques and commercially avail-
able dynamometers to accurately quantify muscle
mass and strength. This has served mainly to reaffirm
the findings of Larsson et al. (1979) and others
reported above. Many of these studies indicate that
the loss of strength is somewhat greater than loss of
muscle mass with aging (Hughes et al. 2001;
Goodpaster et al. 2006; Delmonico et al. 2009)
implying that muscle quality may be reduced. The
quality of functional SM or LTM can be expressed as
strength per unit of tissue. Valid and reliable
measurements of segmental SM or LTM combined
with measures of muscle function e.g. maximal
voluntary strength, allows for the development of an
appropriate index of muscle quality It is suggested
that muscle quality may be able to better distinguish
between those with high and low functional capabil-
ity (Cruz-Jentoft et al. 2010; Hairi et al. 2010).
Since 1992, the BLSA has measured peak torque
(0–308/s) of the arms and legs and non-osseous LTM
(DXA) (Lindle et al. 1997; Lynch et al. 1999). Muscle
strength was reported to have a greater rate of decline
than LTM, this difference began aged *50 y and
increased with age. There was an age associated linear
decline when muscle quality was expressed as knee
extensor torque per CSA or LTM (Metter et al. 1999).
However, the definition of muscle quality is strength
per unit LTM and therefore, in theory, it would seem
more appropriate to express muscle quality as upper
leg (combined knee extensor and flexor) strength per
unit upper leg LTM. To this aim, Lynch et al. (1999)
and Francis et al. (2016b) have expressed the
combined upper leg torque per kg of total and upper
leg LTM respectively. Using this index the decline in
men was 5.1% (Lynch et al. 1999) and *8–10% per
decade in women (Madsen et al. 1997; Francis et al.
2016b). Despite the definition of muscle quality many
authors have chosen to represent muscle quality using
only knee extensor torque per total upper leg SM or
LTM. We have previously reported that the index of
muscle quality becomes more variable when the knee
flexors are included and that knee extensor torque
explained a greater proportion of the variance in the
combined measure. These explanations may explain
the bias in the literature toward using knee extensor
strength only when generating indices of upper leg
muscle quality. In light of these measurement consid-
erations; the preferential decline in knee extensor SM
and strength relative to the knee flexors; and the fact
that the knee extensors are used in power activities that
are usually sustained across the lifespan such as
climbing stairs; we suggest that the most appropriate
Biogerontology
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index of muscle quality is knee extensor torque per
unit SM or LTM (Fig. 1).
The HABC study quantifies muscle quality
directly, based on the density of muscle obtained
using CT images, and indirectly, by dividing knee
extensor torque by muscle mass or volume similar to
the definitions above. Goodpaster et al. (2001)
reported lower muscle attenuation values (density)
with increasing age, body mass index (BMI) and
body fat percentage. Although advancing age and
obesity were associated with reduced muscle density,
the opposite effects were seen with respect to muscle
size. Multiple regression analysis showed that muscle
attenuation was associated with knee extensor torque
(608/s) after accounting for CSA. As muscle atten-
uation values increased so did muscle quality (N m/
cm2), furthermore, men and women with the highest
muscle attenuation values also had the highest
muscle quality. Almost half of the explained variance
in muscle quality was due to attenuation values. The
decline in muscle quality reported from the HABC
study measured as knee extensor torque per unit total
leg LTM is 12.1 and 10.1% per decade for men and
women respectively (Newman et al. 2003). Given
that the decline in total leg LTM, from cross-
sectional analysis, was 9–10% per decade in the
HABC study, it suggests a closer approximation
between SM change and muscle quality change in
those[70 y. Muscle quality (N m/cm2 or N m/kg)
declines in 3 and 5-year longitudinal follow ups were
as high as *19–22% per decade in women and
26–27% in men (Goodpaster et al. 2006; Delmonico
et al. 2009).
Functional capability
The relative effort required to perform functional tasks
increases with advancing age (Landers et al. 2001).
Research designed to report the age-related decline in
functional capability, require measures which can
distinguish meaningful gradations of capacity and
change over a wide range of abilities. Cohorts[50 y
provide a challenge in the heterogeneity of their
functional capabilities. Test batteries need to be able
to reflect activities of daily living (ADL) and yet capture
meaningful performance data relevant to the individual.
As such there is a paucity of literature to report an
estimate of the age-related decline in functional capa-
bility as we have done in the previous sections above.
The SPPB (Guralnik et al. 1994) is the most commonly
employed method of assessing the ability to perform
ADL inmobility limited older adults. The battery uses a
test of gait speed (6 m), lower extremity function (time
taken to rise from a chair 5 times) and balance (semi-
tandem and tandem stands) to make up a 12-point
scoring system. The SPPB was validated in 5000 older
adults ([71 y) and was found to predict nursing home
admission. Since thenmany studies have used the SPPB
to report older adult ([65 y) physical capability (Pahor
et al. 2006; Vasunilashorn et al. 2009; Volpato et al.
2011). Furthermore, performance in this test battery or
components of it have been associatedwith components
of SM and muscle function discussed above.
Although 6–10 m gait speed tests may be consid-
ered highly representative of ADL they may suffer
from either a floor or ceiling effect. In the case of the
floor effect, a frail older adult may not be able to
Fig. 1 Upper leg lean tissue mass (iDXA; University of
Limerick Body Composition Study) and quadriceps skeletal
mass (MRI; Manchester Metropolitan Healthy Ageing Study),
knee extensor torque (isokinetic dynamometry; University of
Limerick Healthy Ageing Study), extended chair rise and gait
speed tests (University of Limerick Healthy Ageing Study)
appear to represent the indices of lower extremity muscle mass,
strength and function responsive to age-related change and
therapeutic intervention
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complete five chair rises and therefore cannot attain
the minimum test score. Alternatively, in the case of
the ceiling effect, the majority of physically active
older adults may achieve the maximum test score,
meaning the test cannot detect meaningful gradations
of capacity and change over a wide range of abilities.
For example, recent evidence from our group (Francis
et al. 2017a) and Glenn et al. (2015) suggest that short
(B10 m) gait speed tests cannot detect change where
expected in healthy older (50–70 y) and middle aged
(55–64 y) adults respectively. This is largely due to
the relative health of both cohorts indicated by a
habitual gait speed (1.4 m/s) far in excess of the gait
speed suggested to be indicative of disability (\0.8 m/
s). Furthermore, the link between muscle mass,
strength and functional capability using these tests
may not be as strong in middle aged or healthy older
adults compared to frail or mobility limited older
adults. For example, Buchner et al. (1996) reported
that the relationship between leg strength and gait
speed (15.2 m) was non-linear. For stronger partici-
pants, there was no relationship between strength and
gait speed but in weaker individuals there was.
Therefore, small changes in physiological capacity
of frail older adults may lead to large changes in
functional capability whereas small changes in phys-
iological capacity of strong adults may lead to no
change in functional capability assessed in this way.
Tests which can allow participants perform to a
greater maximum may be more appropriate to track
age-related change in functional capacity prior to
disablement. The 6 min walk test (Rikli and Jones
1998) and 30 s chair rise test (Jones et al. 1999) were
originally designed to combat the floor effect for i.e.
for participants who could not complete a full test e.g.
five chair rises. However, the authors report the tests as
being capable of detecting difference in functional
capability between the 7th, 8th and 9th decade of life
as well as performance differences between those with
high and low self-reported physical activity. The
construct validity of these tests is underlined by the
fact that these data arise from normative data collected
on 7183 community dwelling older (60–94 y) adults.
Most recently, we reported the 30 s chair rise test and a
900 m extended gait speed test (Fig. 1) as capable of
detecting change in functional capability between the
6th and 7th decade in healthy older adults (Francis
et al. 2017a). Furthermore, knee extensor strength
corrected for body mass and to a lesser extent muscle
quality were associated with functional capability in
healthy older women (Francis et al. 2017b). However,
when both tests were used to assess the efficacy of a
12 week progressive resistance training intervention,
only the 900 m gait speed test was responsive to the
intervention (Francis et al. 2016a). The fact that our
data and others (Hairi et al. 2010) have identified
muscle strength (grip and quadriceps strength) as
having stronger associations with functional capability
than muscle quality may begin to question the
functional significance of muscle quality as a measure
in this context. This is a potentially important finding,
if confirmed, given the considerable increase in time
and expense to measure muscle quality relative to
normalising strength to body mass. This does not
discount muscle quality as an index as it may be
important to understanding physiological changes at
the tissue level.
Other test batteries often retain the core physical
competencies assessed in the SPPB, whilst adding
modifications in order to try and accommodate a
broader range of abilities. The American Alliance for
Health, Physical Education, Recreation & Dance
(AAHPERD) Functional Fitness (Yaguchi and Furu-
tani 1998) includes an extended gait speed test (880
yard walk). Outside of test batteries, the extended gait
speed test (Simonsick et al. 2001) and the ten step stair
climb power test (Bean et al. 2002) have also been
deployed to measure functional capability. None of
these tests however, have the normative data of those
developed by Rikli and Jones. In order to report
functional capability in healthy adults, specifically
lower extremity functional capability across the lifes-
pan, we recommend researchers select tests which
allow participants to perform to a greater maximum.
This would facilitate collection of meaningful perfor-
mance data in conjunction with laboratory measures of
SM and strength. This recommendation is based on
studies which intend to measure healthy well-func-
tioning adults that would not have trouble at least in
walking for 6 min or 900 m and/or completing chair
rises repeatedly for 30 s. In this population, extended
tests may provide meaningful information on the
relative effort required to go for a walk or spend a day
in a town or city. These are activities which may be
impaired prior to a reduction in the ability to complete
basic tasks such as rising from a chair or walking 10 m
and therefore may provide a more sensitive estimate of
functional decline in healthy aging.
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Conclusion
In summary, based on the literature reviewed we
recommend references ranges for LTM or SM are
generated from the thigh region as this appears most
responsive to age-related change or therapeutic inter-
vention. The maximal force generating capacity of the
thigh is best represented from the knee extensors due
to the fact that it represents the majority of the thigh
region, is a more stable measure, plays a greater role in
activities of daily living and undergoes a preferential
decline SM with ageing compared to the knee flexors.
In light of these recommendations we also recommend
that indices of muscle quality are generated using knee
extensor torque per unit SM or LTM. There is a need
for performance measures which can distinguish
gradations of capacity and change over a wide range
of abilities, therefore we recommend researchers use
measures which allow performance to a greater
maximum in order to simultaneously combat potential
floor or ceiling effects.
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